These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 19922821)
1. Intermittent PTH(1-34) does not increase union rates in open rat femoral fractures and exhibits attenuated anabolic effects compared to closed fractures. Tägil M; McDonald MM; Morse A; Peacock L; Mikulec K; Amanat N; Godfrey C; Little DG Bone; 2010 Mar; 46(3):852-9. PubMed ID: 19922821 [TBL] [Abstract][Full Text] [Related]
2. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model. Little DG; McDonald M; Bransford R; Godfrey CB; Amanat N J Bone Miner Res; 2005 Nov; 20(11):2044-52. PubMed ID: 16234978 [TBL] [Abstract][Full Text] [Related]
3. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair. Amanat N; McDonald M; Godfrey C; Bilston L; Little D J Bone Miner Res; 2007 Jun; 22(6):867-76. PubMed ID: 17371160 [TBL] [Abstract][Full Text] [Related]
4. Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. Kakar S; Einhorn TA; Vora S; Miara LJ; Hon G; Wigner NA; Toben D; Jacobsen KA; Al-Sebaei MO; Song M; Trackman PC; Morgan EF; Gerstenfeld LC; Barnes GL J Bone Miner Res; 2007 Dec; 22(12):1903-12. PubMed ID: 17680724 [TBL] [Abstract][Full Text] [Related]
5. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing. Nakazawa T; Nakajima A; Shiomi K; Moriya H; Einhorn TA; Yamazaki M Bone; 2005 Nov; 37(5):711-9. PubMed ID: 16143574 [TBL] [Abstract][Full Text] [Related]
6. Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1-34) in metaphyseal bone healing. Morgan EF; Mason ZD; Bishop G; Davis AD; Wigner NA; Gerstenfeld LC; Einhorn TA Bone; 2008 Dec; 43(6):1031-8. PubMed ID: 18761113 [TBL] [Abstract][Full Text] [Related]
7. Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone. Andreassen TT; Fledelius C; Ejersted C; Oxlund H Acta Orthop Scand; 2001 Jun; 72(3):304-7. PubMed ID: 11480610 [TBL] [Abstract][Full Text] [Related]
8. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. Andreassen TT; Ejersted C; Oxlund H J Bone Miner Res; 1999 Jun; 14(6):960-8. PubMed ID: 10352105 [TBL] [Abstract][Full Text] [Related]
9. A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair. Amanat N; Brown R; Bilston LE; Little DG J Orthop Res; 2005 Sep; 23(5):1029-34. PubMed ID: 16140188 [TBL] [Abstract][Full Text] [Related]
10. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling. McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604 [TBL] [Abstract][Full Text] [Related]
11. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats. Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872 [TBL] [Abstract][Full Text] [Related]
12. Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase. Andreassen TT; Willick GE; Morley P; Whitfield JF Calcif Tissue Int; 2004 Apr; 74(4):351-6. PubMed ID: 15255072 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). Alkhiary YM; Gerstenfeld LC; Krall E; Westmore M; Sato M; Mitlak BH; Einhorn TA J Bone Joint Surg Am; 2005 Apr; 87(4):731-41. PubMed ID: 15805200 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). Nakajima A; Shimoji N; Shiomi K; Shimizu S; Moriya H; Einhorn TA; Yamazaki M J Bone Miner Res; 2002 Nov; 17(11):2038-47. PubMed ID: 12412812 [TBL] [Abstract][Full Text] [Related]
15. Fracture repair: modulation of fracture-callus and mechanical properties by sequential application of IL-6 following PTH 1-34 or PTH 28-48. Rozen N; Lewinson D; Bick T; Jacob ZC; Stein H; Soudry M Bone; 2007 Sep; 41(3):437-45. PubMed ID: 17599848 [TBL] [Abstract][Full Text] [Related]
16. Sequential treatment with intermittent low-dose human parathyroid hormone (1-34) and bisphosphonate enhances large-size skeletal reconstruction by vascularized bone transplantation. Hashimoto T; Shigetomi M; Ohno T; Matsunaga T; Muramatsu K; Tanaka H; Sugiyama T; Taguchi T Calcif Tissue Int; 2007 Sep; 81(3):232-9. PubMed ID: 17674071 [TBL] [Abstract][Full Text] [Related]
17. Effect of intermittent systemic administration of recombinant parathyroid hormone (1-34) on mandibular fracture healing in rats. Rowshan HH; Parham MA; Baur DA; McEntee RD; Cauley E; Carriere DT; Wood JC; Demsar WJ; Pizarro JM J Oral Maxillofac Surg; 2010 Feb; 68(2):260-7. PubMed ID: 20116693 [TBL] [Abstract][Full Text] [Related]
18. Triweekly administration of parathyroid hormone (1-34) accelerates bone healing in a rat refractory fracture model. Kumabe Y; Lee SY; Waki T; Iwakura T; Takahara S; Arakura M; Kuroiwa Y; Fukui T; Matsumoto T; Matsushita T; Nishida K; Kuroda R; Niikura T BMC Musculoskelet Disord; 2017 Dec; 18(1):545. PubMed ID: 29268728 [TBL] [Abstract][Full Text] [Related]
19. Recombinant human parathyroid hormone (PTH 1-34) and low-intensity pulsed ultrasound have contrasting additive effects during fracture healing. Warden SJ; Komatsu DE; Rydberg J; Bond JL; Hassett SM Bone; 2009 Mar; 44(3):485-94. PubMed ID: 19071238 [TBL] [Abstract][Full Text] [Related]
20. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment. Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]